Xumin Zhou
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Gut microbiota and health
Papers in ⓘ
-
- RNA Research and Splicing 5
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
-
- Ferroptosis and cancer prognosis 4
- Prostate Cancer Treatment and Research 2
- Co-authors
- Daojun Lv (10 shared papers)Kaihui Wu (6 shared papers)Wenbin Chen (8 shared papers)Taowei Yang (8 shared papers)Junqi Luo (7 shared papers)Fangpeng Shu (8 shared papers)Libin Zou (6 shared papers)Xiangming Mao (4 shared papers)
- Journals
- Cell Death Discovery (2 papers)Cell Death and Disease (2 papers)Oncotarget (2 papers)Acta Pharmaceutica Sinica B (1 paper)Neoplasia (1 paper)
- Partner nations
- China
In The Last Decade
Xumin Zhou
20 papers receiving 623 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 286
- Molecular Biology 403
- Pulmonary and Respiratory Medicine 186
- Oncology 105
- Immunology 62
Countries citing papers authored by Xumin Zhou
This map shows the geographic impact of Xumin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xumin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xumin Zhou more than expected).
Fields of papers citing papers by Xumin Zhou
This network shows the impact of papers produced by Xumin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xumin Zhou. The network helps show where Xumin Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xumin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis Hit paper breakdown → | 2022 | 132 |
| 2 | 2021 | 78 | |
| 3 | 2020 | 73 | |
| 4 | 2021 | 41 | |
| 5 | 2023 | 40 | |
| 6 | 2021 | 40 | |
| 7 | 2018 | 35 | |
| 8 | 2017 | 34 | |
| 9 | 2022 | 33 | |
| 10 | 2016 | 28 | |
| 11 | 2018 | 24 | |
| 12 | 2021 | 20 | |
| 13 | 2015 | 15 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 6 | |
| 16 | 2023 | 5 | |
| 17 | 2024 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2022 | 2 |
About Xumin Zhou
Xumin Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 22 papers that have together received 627 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), Ferroptosis and cancer prognosis (4 papers), Circular RNAs in diseases (4 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Parasite Biology and Host Interactions (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Cancer Research (286 citations), Molecular Biology (403 citations), Pulmonary and Respiratory Medicine (186 citations), Oncology (105 citations) and Immunology (62 citations). Xumin Zhou has collaborated with scholars based in China. Frequent co-authors include Daojun Lv, Kaihui Wu, Wenbin Chen, Taowei Yang, Junqi Luo, Fangpeng Shu, Libin Zou, Xiangming Mao, Shengren Cen and Zining Long. Their work appears in journals such as Cell Death Discovery, Cell Death and Disease, Oncotarget, Acta Pharmaceutica Sinica B and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.